Alexandria Real Estate Equities Reports Profit Decline as Leasing Demand Weakens

May 1, 2026: Alexandria Real Estate Equities reported a decline in its first-quarter performance, as leasing demand slowed amid macroeconomic uncertainty, impacting both earnings and revenue.

Profit and Revenue Miss Expectations

The company’s adjusted funds from operations (FFO) fell to $1.73 per share, down from $2.30 a year earlier and slightly below market expectations.

Revenue also declined to $671 million, compared to $758.1 million in the same period last year, missing analyst estimates.

Demand Slowdown in Life Sciences Segment

The REIT, which focuses on life sciences offices, laboratories, and tech campuses, is seeing cautious behavior from tenants:

• Companies delaying expansion plans
• Increased focus on optimizing existing space
• Funding constraints in biotech and research sectors

Outlook Remains Stable but Cautious

Despite near-term pressure, the company maintained a stable full-year outlook, narrowing its 2026 FFO guidance to:

• $6.30 – $6.50 per share

Capex Plans Adjusted

Alexandria indicated that construction spending beyond 2026 may reduce by around $500 million, depending on market conditions—signaling a cautious expansion strategy.

Market Reaction

Following the announcement, the company’s shares declined by around 2% in after-hours trading.

Industry Insight

The update reflects a broader trend in the US commercial real estate sector, where leasing activity is slowing, particularly in specialized segments like life sciences, due to global economic uncertainty.